Industry Insights

By: Stephen M. Hahn, M.D., Commissioner of Food and Drugs, Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research and Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research The coronavirus (COVID-19) pandemic is an...

Healthmark has launched new customized signs to help health care facilities communicate important messages during this challenging time. In order to encourage and remind individuals of necessary steps to practice during this pandemic, Healthmark released COVID-19...

On April 20, the U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA issued information on the use of serological (antibody) tests to help identify people who may have been exposed to...

Ten nurses from the Providence Saint John’s Health Center in California were reportedly placed on administrative leave for refusing to treat COVID-19 patients without access to N95 respirators. At the time they were suspended, it is claimed that these nurses...

As the world struggles with the coronavirus (COVID-19) outbreak, Asian countries are galvanizing every digital tool at their disposal to curb the spread and better manage the evolving pandemic. Using digital contact tracing, governments have begun a massive exercise...

The Ohio State University Wexner Medical Center is the first health system in Ohio to launch a new clinical trial that uses inhaled nitric oxide to improve coronavirus outcomes and keep COVID-19 patients out of intensive care. Researchers are administering...